Both in Pharmaceuticals
Latigo Biotherapeutics vs Rigel Pharmaceuticals Inc. (New)
Over the past year LTGO returned −38.1% and RIGL returned +6.7%; their daily moves had a correlation of 0.24.
LTGO −38.1% RIGL +6.7%Growth of $1, one year, split-adjusted
| Metric | LTGO | RIGL |
|---|---|---|
| Price | $13.72 | $50.39 |
| Market cap | $909.3M | $941.2M |
| Today | −1.68% | −1.80% |
| 1 month | −13.7% | +6.9% |
| 6 months | — | +70.6% |
| Year to date | — | +17.6% |
| 1 year | — | +59.3% |
| Revenue growth (YoY) | — | −22.6% |
| Gross margin | — | 89.2% |
| Net margin | — | 22.0% |
| P/E (TTM) | — | 2.9× |
| Price / sales | — | 3.4× |
| Net cash | — | $56.1M |
| Dividend yield | — | — |
| Volatility (60d) | — | 36.5% |
| Short % of float | 1.6% | 16.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).